Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07295678 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

URGO FilmoCream Eczema + Dermocorticoids in Atopic Dermatitis

Study acronym: GERONIMO
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 26, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Interventions: Dermocorticoid alone (Drug), URGO FilmoCream Eczema plus dermocorticoid (Combination Product) to Follow-up period after dermocorticoid treatment alone (Drug), Follow-up period after treatment with URGO Filmocream Eczema associated with…v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical study is to determine whether URGO FilmoCream Eczema is effective as a non-steroidal treatment to relieve symptoms of atopic dermatitis. It also aims to evaluate the cream's ability to moisturize, soothe irritation, protect the skin, and promote healing of eczema lesions. The main questions the study seeks to answer are: 1. Does URGO FilmoCream Eczema improve symptom relief of atopic dermatitis when used alongside standard topical corticosteroid treatment? 2. How do eczema lesions treated with topical corticosteroids alone progress and heal compared to those treated with topical corticosteroids plus URGO FilmoCream Eczema? To investigate this, patients with at least two similar eczema lesions are enrolled. One lesion is treated with topical corticosteroids alone, while the other is treated with topical corticosteroids plus URGO FilmoCream Eczema. The progression of both lesions is monitored throughout treatment, until healing, and for 28 days after the last application of topical corticosteroids.
Trial Details
NCT Number NCT07295678
Lead Sponsor CEN Biotech
Collaborators: Eurofins Dermscan Pharmascan, URGO Recherche, Innovation et Développement
Conditions
(from sponsor)		 Atopic Dermatitis
Related terms Dermatitis, Atopic
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov